Stages of arterial hypertension and parameters of pacing in patients after implantation and drug therapy at the annual stage
Vol 84 No 3 (2019), Therapy
Vol 84 No 3 (2019)

Stages of arterial hypertension and parameters of pacing in patients after implantation and drug therapy at the annual stage

Therapy
https://doi.org/10.35339/ekm.2019.84.03.03
Published August 19, 2020
Т.А. Derienko
VN Karazin Kharkiv National University
https://orcid.org/0000-0002-2479-2896
Т.М. Tykhonova
VN Karazin Kharkiv National University
https://orcid.org/0000-0001-9196-9113
L.O. Martumianova
VN Karazin Kharkiv National University
https://orcid.org/0000-0002-1638-4630
PDF (Русский)

Keywords

pacing
the stage of hypertension
modes of stimulation

How to Cite

DerienkoТ., TykhonovaТ., & Martumianova, L. (2020). Stages of arterial hypertension and parameters of pacing in patients after implantation and drug therapy at the annual stage. Experimental and Clinical Medicine, 84(3), 19-23. https://doi.org/10.35339/ekm.2019.84.03.03
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

129 patients (69 men and 60 women) aged (69.5±11.6) were observed at the annual stage after the implantation of cardiac pacemaker and drug therapy in the DDD / DDDR and VVI / VVIR modes of stimulation. Patients were divided into 2 groups-II and III stages of AH. In early postoperative, in the semiannual and annual periods after the implantation, depending on the stage of hypertension were estimated: the base frequency of stimulation, atrioventricular delay (stimulated and detected), ventricular stimulation threshold, ventricular electrode impedance, percentage of ventricular stimulation. The results showed that there was no significant difference in the changes in the parameters of stimulation between the DDD / DDDR and VVI / VVIR modes in patients with implanted cardiac pacemaker and AH. AH III against stage II requires a higher ventricular stimulation threshold, ventricular electrode impedance, AV delay of stimulated and detected complexes, percentage of ventricular stimulation than stage II of AH at all stages of observation. Careful drug support of patients with AH after the implantation of cardiac pacemaker with the account of the stage of hypertension allows to improve the parameters of pacemaker
https://doi.org/10.35339/ekm.2019.84.03.03
PDF (Русский)

References

Falk V., Starck C. (2016). Cardiac pacing – Will the future be exclusively leadless?. Expert Rev Med Devices., pp. 2–421.

Kolomitseva I.N., Volkov D.E., Lopin D.A., Yabluchanskiy N.I. (2015). Funktsionalnyiy klass hronicheskoy serdechnoy nedostatochnosti i parametryi elektrokardiostimulyatorov v rannem posleimplantatsionnom periode [The functional class of chronic heart failure and the parameters of pacemakers in the early post-implantation period]. Odeskiy medichniy zhurnal – Odessa Medical Journal, № 3 (149), pp. 39–41 [in Russian].

Li S., Zhou F., Lu Y. et al. (2016). Hypertension related knowledge and behaviour associated with awareness, treatment and control of hypertension in a rural hypertensive population: a community based, cross-sectional survey. Blood Press, pp. 1–7.

Maltseva M.S. (2014). QTC interval duration class and stimulation parameters in patience during first six months after pacemaker. J.V.N. Karazin` KhNU. № 29, pp. 39–44.

Shanina I.V., Volkov D.E., Lopin D.A. (2013). QRS complex duration and clinical features of patient with permanent pacemakers. J.V.N. Karazin` KhNU, vol. 1044, pp. 42–44.

RekomendatsIi Ukrayinskoi AsotsIatsIi kardIologIv z profIlaktiki ta lIkuvannya arterIalnoi gIpertenzIi. PosIbnik do NatsIonalnovi programi profIlaktiki I lIkuvannya arterIalnoi gIpertenzIi. – K.: PP VMB; 2008. – 80 p. 4e vidannya, vipravlene I dopovnene. рр.8-11

Mitov V., Perišić Z., Jolić A. et al. (2013). The effect of right ventricle pacemaker lead position on lead stability // Timocki medicinski clasnik, vol. 38, pp. 129–132.